Becker's Healthcare January 31, 2025
Alexandra Murphy

Drugmakers have raised the list prices of more than 800 prescription drugs — ranging from blood pressure medications to cancer treatments — by a median of 4% at the start of this year, The Wall Street Journal reported Jan. 28.

Here are five things to know:

  1. This modest price increase is a dip from last year’s 4.5% rise, reflecting a cautious approach as drug companies may try to avoid criticism from President Donald Trump while seeking his support for key industry priorities, the report said.
  2. The price hikes affect well-known drugs produced by companies such as Pfizer, Novartis and Bristol-Myers Squibb, according to an analysis for the Journal by 46brooklyn, a nonprofit research group.
  3. The...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Building Resilience: CDMO Strategies for Drug Supply Chain Stability
Metsera’s IPO Raises $275M to Show How Its Obesity Drugs Can Top Current GLP-1s
How will CMS administer the IRA Medicare Drug Price Negotiation under Trump?
STAT+: How Trump’s tariffs may raise health care costs, from medical devices to prescription drugs
One Institution’s Evidence-Based Approach to Adopting Biosimilars

Share This Article